Added to YB: 2026-03-12
Pitch date: 2026-03-10
TSTL.L [neutral]
Tristel plc
+1.18%
current return
Author Info
Mahad is a contrarian value investor with a focus on DCF analysis and a disciplined margin of safety approach. Sign up for the newsletter.
Company Info
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.
Market Cap
GBP 182.1M
Pitch Price
GBP 3.83
Price Target
4.48 (+16%)
Dividend
3.74%
EV/EBITDA
13.80
P/E
23.40
EV/Sales
3.53
Sector
Health Care Equipment and Supplies
Category
growth
H1 2026 Updates: Tristel
TSTL.L (update): H1 saw chlorine dioxide validated in US ultrasound guidelines; new VISICLEAN detergent launched. US OPH rev just $88k (160 accounts evaluating), ultrasound royalties $153k. Gross margin 81% (-1pp) on in-house wipe transition. CEO departing after 16mo. DCF suggests 18% upside but hinges on US scale-up & leadership stability.
Read full article (3 min)